Research graph

References

References from KRAS-driven metabolic reprogramming of enhanced MFSD2A-mediated lysophosphatidylcholine scavenging promotes survival and progression of pancreatic ductal adenocarcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.

No reference evidence is available for this admitted work.